Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23914323 | 1.00 | CYP19A1 (0.39) | CYP19A1GAAHDAC4NPSR1HPGD | |
| SCHEMBL23914093 | 0.87 | CYP19A1 (0.42) | CYP19A1SMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL23914092 | 0.87 | CYP19A1 (0.42) | CYP19A1SMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL23913983 | 0.72 | SMN1; SMN2 (0.39) | CYP19A1SMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL6980797 | 0.72 | SMN1; SMN2 (0.40) | GAAHDAC4NPSR1SMN1; SMN2MEN1 | |
| SCHEMBL5442142 | 0.72 | SMN1; SMN2 (0.39) | CYP19A1SMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL23914451 | 0.72 | SMN1; SMN2 (0.39) | CYP19A1SMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL23913984 | 0.72 | SMN1; SMN2 (0.39) | CYP19A1SMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL23914452 | 0.72 | SMN1; SMN2 (0.39) | CYP19A1SMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL14427618 | 0.72 | SMN1; SMN2 (0.39) | CYP19A1SMN1; SMN2MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | CYP19A1 2911/4885GAA 2417/4885HDAC4 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.